Nuance Pharma

Executive Summary

Nuance Pharma is a commercial-stage biopharmaceutical company based in Shanghai, China, focused on developing and commercializing innovative biologics for respiratory and cardiovascular diseases. With a strategy that combines in-licensed and internally developed assets, the company targets major chronic conditions with large patient populations in China and globally. Founded in 2014, Nuance has built a pipeline that leverages both local expertise and global partnerships to address significant unmet medical needs. As a private company with a commercial-stage presence, it has already demonstrated an ability to bring products to market, positioning it for continued growth in the rapidly expanding Chinese biopharma sector.

Upcoming Catalysts (preview)

• 2026New Product Approval or Launch in China70% success
• 2026Strategic Partnership or Licensing Deal for Pipeline Asset60% success
• 2027Positive Phase 3 Data Readout for Key Asset55% success